The Valley Fever Center for Excellence at the University of Arizona in Tucson has received a four-year, $4.8 million grant to help with the development of a vaccine for Valley fever.
Dr. John Galgiani is the center’s director said that "two out of every three infections in the United States now occur in Arizona. So it’s really our localized area, and it's very intensely endemic, it's almost not found in New York for example."
He says the vaccine will first be used in dogs. He says eventually it will be evaluated to be used in humans.
